Международный консорциум генетики лития (ConLiGen): достижения и сотрудничество
Аннотация
Об авторе
У. ХейлброннерГермания
Список литературы
1. Amare A.T., Schubert K.O., Hou L., Clark S.R., Papiol S., Heilbronner U., … Baune B.T. Association of Polygenic Score for Schizophrenia and HLA Antigen and Inflammation Genes With Response to Lithium in Bipolar Affective Disorder: A Genome-Wide Association Study. JAMA Psychiatryю 2018;75(1):65–74. https://doi.org/10.1001/jamapsychiatry.2017.3433
2. Garnham J., Munro A., Slaney C., Macdougall M., Passmore M., Duffy A., Alda M. Prophylactic treatment response in bipolar disorder: Results of a naturalistic observation study. Journal of Affective Disorders. 2007;104(1–3):185–190. https://doi. org/10.1016/j.jad.2007.03.003
3. Grof P., Duffy A., Cavazzoni P., Grof E., Garnham J., MacDougal, M., Alda M. Is response to prophylactic lithium a familial trait? The Journal of Clinical Psychiatry. 2002;63(10):942–947. https:// doi.org/10.4088/jcp.v63n1013
4. Hou L., Bergen S.E., Akula N., Song J., Hultman C.M., Landén M., … McMahon F.J. Genome-wide association study of 40,000 individuals identifies two novel loci associated with bipolar disorder. Human Molecular Genetics. 2016;25(15):3383–3394. https://doi.org/10.1093/hmg/ddw181
5. Hou L., Heilbronner U., Degenhardt F., Adli M., Akiyama K., Akula N., … Schulze T.G. Genetic variants associated with response to lithium treatment in bipolar disorder: A genome-wide association study. The Lancet. 2016;387(10023):1085–1093. https://doi.org/10.1016/S0140-6736(16)00143-4
6. Kalman J.L., Papiol S., Forstner A.J., Heilbronner U., Degenhardt F., Strohmaier J., Schulze T. G. Investigating polygenic burden in age at disease onset in bipolar disorder: Findings from an international multicentric study. Bipolar Disorders. 2019;21(1):68–75. https://doi.org/10.1111/ bdi.12659
7. Manchia M., Adli M., Akula N., Ardau R., Aubry J.-M., Backlund L., Alda M. Assessment of Response to Lithium Maintenance Treatment in Bipolar Disorder: A Consortium on Lithium Genetics (ConLiGen) Report. PLoS ONE. 2013;8(6):e65636. https://doi.org/10.1371/journal.pone.0065636
8. Papiol S., Schulze T.G., Alda M. Genetics of Lithium Response in Bipolar Disorder. Pharmacopsychiatry. 2018;51(5):206–211. https://doi. org/10.1055/a-0590-4992
9. Pisanu C., Heilbronner U., Squassina A. The Role of Pharmacogenomics in Bipolar Disorder: Moving Towards Precision Medicine. Mol Diagn Ther. 2018;22(4):409–420. https://doi.org/10.1007/ s40291-018-0335-y
10. Reinbold C. S., Forstner A. J., Hecker J., Fullerton J. M., Hoffmann P., Hou L., Cichon S. Analysis of the Influence of microRNAs in Lithium Response in Bipolar Disorder. Front Psychiatry. 2018;9:207. https://doi.org/10.3389/fpsyt.2018.00207
11. Schulze T.G., Alda M., Adli M., Akula N., Ardau R., Bui E.T., McMahon F.J. The International Consortium on Lithium Genetics (ConLiGen): An initiative by the NIMH and IGSLI to study the genetic basis of response to lithium treatment. Neuropsychobiology. 2010;62(1):72–78. https://doi. org/10.1159/000314708
12. Scott J., Etain B., Manchia M., Brichant-Petitjean C., Geoffroy P., Schulze T., ConLiGen collaborators. An examination of the quality and performance of the Alda scale for classifying lithium response phenotypes. Bipolar Disorders. 2019; https:// doi.org/10.1111/bdi.12829
Рецензия
Для цитирования:
Хейлброннер У. Международный консорциум генетики лития (ConLiGen): достижения и сотрудничество. Обозрение психиатрии и медицинской психологии имени В.М.Бехтерева. 2019;(4-1):51-52. https://doi.org/10.31363/2313-7053-2019-4-1-51-52
For citation:
Heilbronner U. The International Consortium of Lithium Genetics (ConLiGen): Achievements and Collaborations. V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY. 2019;(4-1):51-52. https://doi.org/10.31363/2313-7053-2019-4-1-51-52